HD-OPM Archive
Topics › Supplements & vitamins

Berberine inhibits PCSK9 and modestly lowers LDL, far less than PCSK9 drugs

Louis Nervegna · Jun 21, 2025 · ♥ 11 reactions · 10 comments · original Facebook post
Supplements & vitaminsLDL, ApoB & lipid panelPCSK9, ezetimibe & newer drugs
AI summary & key facts

Louis notes berberine is a cheap oral compound that inhibits PCSK9 and modestly lowers cholesterol. He would never discourage PCSK9 drugs for high-risk people, but suggests berberine may be worth considering for primary prevention in someone at low 10-year risk, while stressing its LDL lowering is much smaller.

(no text — see the shared post below)

Research cited

Berberine is a natural way to inhibit PCSK9. It modestly lowers cholesterol in many people.

It’s been used in the traditional medicines of various cultures for over 3000 years. Berberine is cheap and easy to administer orally, unlike the new PCSK9 inhibiting drugs.

I would never discourage someone at high risk from taking PCSK9 drugs. That is a case where benefit far outweighs risk. But for primary prevention in someone at reasonably low 10 year risk, berberine might be worth considering— though it is much less effective at lowering LDL than the PCSK9 drugs. The LDL lowering effect from berberine is modest in comparison.

Paper · EXCLI J · 2022Berberine: Ins and outs of a nature-made PCSK9 inhibitor.Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a secreted protein and a critical regulator of low-density lipoprotein-cholesterol (LDL-C) through inducing degradation of the LDL receptor (LDLR) within the hepatocyte lysosome. PCSK9 deficiency significantly improves the survival rate of cardiovascular disease (CVDs) patients. Up to now, various PCSK9 inhibition approaches have been tested. However, the…ncbi.nlm.nih.gov

#berberineHD #pcsk9HD

← newer: Harvard/MGH recruits for a randomized trial of white potatoeolder: Family Heart Foundation offers a free at-home Lp(a) and LDL →